Suchen

Schlüsselwörter:

Creator ID:

Typ:

Kategorien:

Sprachen:

Ausrichtung:

Farbe:

Model property release:

Laufzeit Video:

Resultat (0)

Automatisch Seiten erstellen (Auto paging)

Menue

Major histocompatibility complex proteins (MHC) I and II on the surface of a dendritic cell

Major histocompatibility complex proteins (MHC) I and II on the surface of a dendritic cell

The peptide tirzepatide (Mounjaro) activating the GLP-1 receptor

The peptide tirzepatide (Mounjaro) activating the GLP-1 receptor

Neutralizing monoclonal antibody binding to influenza virus hemagglutinin

Neutralizing monoclonal antibody binding to influenza virus hemagglutinin

Neurons with Lewy bodies

Neurons with Lewy bodies

Exosomes, cross section showing proteins and mRNA

Exosomes, cross section showing proteins and mRNA

Organoid tissue. An organoid is a miniaturized and simplified version of an organ produced in vitro.

Organoid tissue. An organoid is a miniaturized and simplified version of an organ produced in vitro.

Immunotherapy of Alzheimer's disease. Antibody binding to an amyloid beta fibril.

Immunotherapy of Alzheimer's disease. Antibody binding to an amyloid beta fibril.

Exosomes, cross section showing proteins and mRNA

Exosomes, cross section showing proteins and mRNA

PTEN-induced kinase 1 (PINK1) phosphorylates ubiquitin (yellow) on the outer mitochondrial membrane. Parkin (red) will bind afterwards to ubiquitin.

PTEN-induced kinase 1 (PINK1) phosphorylates ubiquitin (yellow) on the outer mitochondrial membrane. Parkin (red) will bind afterwards to ubiquitin.

The enzyme New Delhi Metallo-beta-Lactamase-1 (NDM-1, blue) in complex with the flavonol inhibitor morin. NDM1 has devoloped to a global threat by confering resistance to all common β-lactam antibio

The enzyme New Delhi Metallo-beta-Lactamase-1 (NDM-1, blue) in complex with the flavonol inhibitor morin. NDM1 has devoloped to a global threat by confering resistance to all common β-lactam antibio

T-cell receptors and CD8 and CD4 co-receptors on a killer and a helper T-cell

T-cell receptors and CD8 and CD4 co-receptors on a killer and a helper T-cell

Chikungunya viruses. The Chikungunya disease has become a global health concern.

Chikungunya viruses. The Chikungunya disease has become a global health concern.

The RNA polymerase II transcribing DNA into RNA.

The RNA polymerase II transcribing DNA into RNA.

Neutralizing monoclonal antibody in complex with Herpex Simplex virus 1 (HSV 1) glycoprotein B trimer

Neutralizing monoclonal antibody in complex with Herpex Simplex virus 1 (HSV 1) glycoprotein B trimer

Activated spliceosome. The spliceosome removes non-coding regions (introns) from pre-mRNA, leaving the coding regions (exons) to form mature mRNA.

Activated spliceosome. The spliceosome removes non-coding regions (introns) from pre-mRNA, leaving the coding regions (exons) to form mature mRNA.

The vascular endothelial growth factor (VEGF) promotes blood vessel formation (angiogenesis)

The vascular endothelial growth factor (VEGF) promotes blood vessel formation (angiogenesis)

Oncogene: DNA mutation leads to mutated KRAS protein

Oncogene: DNA mutation leads to mutated KRAS protein

LDL particles. Low-density lipoprotein particles transport lipids like cholesterol, phospholipids and triglycerids

LDL particles. Low-density lipoprotein particles transport lipids like cholesterol, phospholipids and triglycerids

UCC118 Rool RNA (hexameric RNA). Stable RNA-based therapeutics.

UCC118 Rool RNA (hexameric RNA). Stable RNA-based therapeutics.

Tumor

Tumor

Immune checkpoint inhibitors: PD-1, CTLA-4 and PD-1 blocked by therapeutic antibodies

Immune checkpoint inhibitors: PD-1, CTLA-4 and PD-1 blocked by therapeutic antibodies

Epigenetics: DNA methylation by the DNA methyl transferase I (DMNT1)

Epigenetics: DNA methylation by the DNA methyl transferase I (DMNT1)

Argonaute protein complexed with double stranded microRNA. Guide miRNA strand in red.

Argonaute protein complexed with double stranded microRNA. Guide miRNA strand in red.

The GLP-receptor agonist tirzepatide (Mounjaro) before binding and bound to the receptor

The GLP-receptor agonist tirzepatide (Mounjaro) before binding and bound to the receptor

Major histocompatibility complex proteins (MHC) I and II on the surface of a dendritic cell. Left MHC I, right MCH II. MHCII presents generally longer antigenic peptides (red) than MHC I.

Major histocompatibility complex proteins (MHC) I and II on the surface of a dendritic cell. Left MHC I, right MCH II. MHCII presents generally longer antigenic peptides (red) than MHC I.

GLP-1 receptor, inactivated and surrounded by an agonist (semaglutide, red) and G-proteins

GLP-1 receptor, inactivated and surrounded by an agonist (semaglutide, red) and G-proteins

Cancer immunotherapy: Therapeutic antibodies block HER2

Cancer immunotherapy: Therapeutic antibodies block HER2

26S proteasome. Proteasomes degrade unneeded or damaged proteins.

26S proteasome. Proteasomes degrade unneeded or damaged proteins.

Epigenetics: DNA methyl transferase I (DMNT1) methylates DNA

Epigenetics: DNA methyl transferase I (DMNT1) methylates DNA

Human epidermal growth factor receptor 2 (HER2) and HER3, pro-oncogenic complex

Human epidermal growth factor receptor 2 (HER2) and HER3, pro-oncogenic complex

The amyloid beta peptide bound to the cell membrane, the free form aggregates to amyloid plaques.

The amyloid beta peptide bound to the cell membrane, the free form aggregates to amyloid plaques.

The vascular endothelial growth factor receptor activated by VEGF. The activation leads to blood vessel formation.

The vascular endothelial growth factor receptor activated by VEGF. The activation leads to blood vessel formation.